4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001415889-25-010290
CHIEF EXECUTIVE OFFICER acquired 49,367 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2025-04-04 | Option exercise | +49,367 | $0.30 | $14,810 | 302,223 | D |
| Derivatives | |||||||
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2025-04-04 | Option exercise · Employee Stock Option (right to buy) | −49,367 | 252,444 | D | ||
Loading xslF345X05/form4-04072025_040401.xml…